Evidence map›Paper›PMID 41053540›Full record

ArticleCellular & molecular biology letters2025

LncRNA-like MMP14 RNA facilitates colorectal cancer metastasis by suppressing H3K27cr at the STARD13 promoter region.

Mengting Li, Ying Gao, Xiaolin Sun, Wendan Zheng, Mengzhen Zhang, Chenlong Wang, Weiwei Chu, Xuemei Yang, Lin Wang, Maojin Zheng and 4 more

Abstract read
In one paragraph

Article in Cellular & molecular biology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mengting Li *Department of Pathology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Ying Gao *Department of Anesthesiology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, 233099, People's Republic of China.
Xiaolin Sun *Department of Pathology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Wendan ZhengDepartment of Pathology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Mengzhen ZhangDepartment of Pathology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Chenlong WangDepartment of Pathology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Weiwei ChuDepartment of Plastic Surgery, The First Affiliated Hospital of Bengbu Medical University, Bengbu, 233099, People's Republic of China.
Xuemei YangDepartment of Pathology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Lin WangDepartment of Pathology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Maojin ZhengDepartment of Pathology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Wenzhi XueDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (SJTUSM), Shanghai, China.
Fuxing DongPublic Experimental Research Center, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Dongsheng PeiDepartment of Pathology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China. dspei@xzhmu.edu.cn.ORCID http://orcid.org/0000-0002-8053-3741
Meijian LiaoDepartment of Pathology, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China. liaomeijian@xzhmu.edu.cn.

Funding

Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions 24KJB320023
6 · The paper itself

Abstract

backgroundMMP14 protein has been recognized to promote tumor metastasis through protease activity, yet drugs targeting the protein fail to improve survival rates, suggesting the presence of non-protein regulatory mechanisms. This study aims to explore the roles and mechanisms by which MMP14 RNA facilitates colorectal cancer (CRC) metastasis.

methodsTranswell assays and animal experiments utilizing loss-of-function and gain-of-function approaches were employed to assess the roles of MMP14 RNA in facilitating CRC metastasis. A combination of immunoprecipitation assays, scRNA-seq analysis, and western blotting was conducted to elucidate the underlying mechanisms by which MMP14 RNA promoted CRC metastasis.

resultsOur study revealed that MMP14 RNA was highly expressed in CRC tissues and correlated with poor prognosis. The overexpression of MMP14 RNA facilitated metastasis both in vitro and in vivo. Mechanistically, MMP14 RNA interacted with the distal promoter of STARD13 and bound to the N-terminal of SIRT3, facilitating its recruitment to the promoter region. This cascade of events reduced H3K27cr levels at the STARD13 promoter, thereby inhibiting STARD13 transcription and ultimately promoting CRC metastasis. Furthermore, we proved that silencing MMP14 RNA had a more significant inhibitory effect on tumor metastasis compared with inhibiting the MMP14 protein.

conclusionsThe study elucidated an lncRNA-like mechanism by which MMP14 RNA facilitated CRC metastasis via RNA-directed chromatin remodeling.

Indexed as

Colorectal NeoplasmsMatrix Metalloproteinase 14Promoter Regions, GeneticRNA, Long NoncodingAnimalsCell Line, TumorCell MovementFemaleGene Expression Regulation, NeoplasticHumansMaleMiceMice, Inbred BALB CMice, NudeNeoplasm MetastasisMatrix Metalloproteinase 14MMP14 protein, humanRNA, Long NoncodingColorectal cancerHistone crotonylationLncRNA-likeMetastasisMMP14

Identifiers

PMID41053540
PMCPMC12502449

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.